Brandtree

Who owns Doril?

Doril is owned by Hypera (Brazil, B3: HYPE3).[1]

This ownership is reported in official statements but has not yet been matched to a regulatory filing.

Key facts

Current owner
Hypera Pharma reported
Owned since
Not recorded
Previous owner
None recorded
Owner HQ
🇧🇷 Brazil, São Paulo
Origin
🇧🇷 Brazil
Category
Consumer healthOver-the-counter medicinePain relief
Parent ticker
B3: HYPE3
Last verified
· 1 sources

About Doril

Doril is a Hypera Pharma painkiller and fever reducer known by the slogan "Tomou Doril, a dor sumiu" ("Took Doril, the pain went away"). The range covers standard Doril tablets for pain, fever and headache, Doril Enxaqueca for migraine and period pain, and Doril Pro for inflammatory pain such as sore throat, back pain and tendinitis.

Ownership timeline of Doril

  1. ? – present Hypera [1] reported

Where Doril sits in Hypera

Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.

Where Doril sits in Hypera Tree of 8 brands under Hypera. Hypera Doril Benegrip Biotônico Fontoura Engov Epocler Estomazil and 2 more

Open the full Hypera ownership tree →

Other brands owned by Hypera in consumer health

See the full Hypera brand portfolio (8) →

Latest news about Doril

No tagged news items yet. Deals, regulatory actions and recalls are added from SEC filings, regulators and trade press; only titles and links are stored.

Headlines link to the original publisher. Brandtree does not reproduce article text.

Frequently asked questions

Who is the parent company of Doril?

The parent company of Doril is Hypera, a publicly listed company headquartered in Brazil.

Is Doril Brazilian?

Yes. Doril originated in Brazil and its owner, Hypera, is also headquartered in Brazil.

Is Doril still owned by Hypera?

Yes. As of 16 September 2026, Doril is still owned by Hypera. The ownership record was last checked against primary sources on that date.

Sources (1) & corrections

Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.

  1. [1] Hypera Pharma — Corporate Profile (investor relations, updated 18 June 2026) — Hypera Pharma, Official document, published 18 June 2026; retrieved 16 September 2026.

Report a correction Opens a pre-filled GitHub issue. See our corrections policy.